NASDAQ:ADGM

Adagio Medical Q4 2025 Earnings Results & Report

Adagio Medical logo
$1.75 +0.09 (+5.42%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$1.75 +0.00 (+0.11%)
As of 11/20/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Adagio Medical beat analyst earnings expectations in its Q4 2025 results, released March 27, 2026. The company reported EPS of -$6.30 versus the -$9.30 consensus estimate.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens
Conference Call
8:00 AM ET

Adagio Medical EPS Results

Actual EPS
-$6.30
Consensus EPS
-$9.30
Beat/Miss
Beat by +$3.00
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 4 quarters

Adagio Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Adagio Medical Q4 2025 Earnings FAQ

Adagio Medical (NASDAQ:ADGM) reported earnings of -$6.30 per share for Q4 2025, beating the consensus estimate of -$9.30. The report was announced on Friday, March 27, 2026.

Adagio Medical Earnings Headlines

Adagio Medical Reports Third Quarter 2026 Results
The next convergence is here
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
Adagio Medical (ADGM) Expected to Post Earnings on Wednesday
ADGM - Adagio Medical Holdings, Inc.
See More Adagio Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Adagio Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adagio Medical and other key companies, straight to your email.

About Adagio Medical

Adagio Medical (NASDAQ:ADGM) is a medical technology company developing catheter-based systems for treating cardiac arrhythmias. Its technology uses ultra-low-temperature cryoablation, which applies very cold temperatures to create lesions in heart tissue that can interrupt abnormal electrical signals.

The company’s platform includes the vCLAS system, designed for ventricular arrhythmias such as ventricular tachycardia, and the iCLAS system, designed for atrial fibrillation. These systems are intended for use in catheter ablation procedures by cardiac electrophysiology teams.

View Adagio Medical Profile